Abstract
Neuroimaging has revealed that migraine is linked to alterations in both the structure and function of the brain. However, the re-lationship of these changes with aging has not been studied in detail. Here we employ the Brain Age framework to analyze migraine, by building a machine learning model that predicts age from neuroimaging data. We hypothesize that migraine pa-tients will exhibit an increased Brain Age Gap (the difference between the predicted age and the chronological age) compared to healthy participants. We trained a machine learning model to predict Brain Age from 2,771 T1-weighted magnetic resonance imaging scans of healthy subjects. The processing pipeline in-cluded the automatic segmentation of the images, the extraction of 1,479 imaging features (both morphological and intensity-based), harmonization, feature selection and training inside a 10-fold cross-validation scheme. Separate models based only on morphological and intensity features were also trained, and all the Brain Age models were later applied to a discovery cohort composed of 247 subjects, divided into healthy controls (HC, n=82), episodic migraine (EM, n=91), and chronic migraine pa-tients (CM, n=74). CM patients showed an increased Brain Age Gap compared to HC (4.16 vs -0.56 years, P=0.01). A smaller Brain Age Gap was found for EM patients, not reaching sta-tistical significance (1.21 vs -0.56 years, P=0.19). No associa-tions were found between the Brain Age Gap and headache or migraine frequency, or duration of the disease. Brain imag-ing features that have previously been associated with migraine were among the main drivers of the differences in the predicted age. Also, the separate analysis using only morphological or intensity-based features revealed different patterns in the Brain Age biomarker in patients with migraine. The brain-predicted age has shown to be a sensitive biomarker of CM patients and can help reveal distinct aging patterns in migraine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by research grants PID2021-124407NB-I00, funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, TED2021-130758B-I00, funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR and PRE2019-089176 funded by MCIN/AEI/10.13039/501100011033 and ESF ESF invests in your future.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research was authorized by Hospital Clínico Universitario de Valladolid local Ethics Committee (PI: 14- 197).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The previous version represented an abstract presented at the conference of the International Society for Magnetic Resonance in Medicine in Toronto in 2023. This version is an extended work that includes more data and evaluates the significance of the features used.
Data Availability
The public datasets used during the current study are available either online or after reasonable request. The institutional dataset used is also available author upon reasonable request to the corresponding author. The code used for modeling and data analysis is accessible at https://github.com/rafaloz/MigraineBA/
https://fcon_1000.projects.nitrc.org/indi/retro/dlbs.html
http://fcon_1000.projects.nitrc.org/indi/CoRR/html/concept.html
https://openneuro.org/datasets/ds003592
http://fcon_1000.projects.nitrc.org/indi/retro/sald.html